Dr. Shaoulian is very caring and knowledgeable. His office staff is also wonderful. I highly recommend him.
Natan Shaoulian, MD
(12)
Photos
The Neurology Muscular Dystrophy and Neuropathy Institute, led by Dr. Natan Shaoulian, specializes in treating a range of neurological conditions including neuropathy, muscular dystrophy, and fibromyalgia. Dr. Shaoulian, a board-certified neurologist, focuses on neuromuscular disorders and offers advanced treatments such as EMG/Nerve Conductions Studies and muscle biopsies.
Dr. Shaoulian is known for his expertise in diagnosing and treating complex cases of neuropathy, with a high success rate in reversing severe conditions. Patients at the institute receive individualized attention, thorough evaluations, and access to state-of-the-art diagnostic technologies to ensure accurate diagnoses and effective treatment plans.
With a commitment to spending quality time with each patient, Dr. Shaoulian emphasizes patient education and communication throughout the diagnostic and treatment processes. The institute prioritizes patient understanding, providing detailed explanations of conditions, diagnoses, and treatment options to empower patients in their healthcare journey.
Generated from the website content
Also at this address
Reviews
Received services 7/2/2024. Both insurances paid in August of 2024. Just now 6/17/2025 I am just receiving a co-pay. This is totally unacceptable. I was aware that Anthem is slow but they paid...
This is the oddest and most bizarre business I have encountered! I am a 35+ year, now retired Chiropractor. I was seeking information for specialized treatment of a family member suffering from...
The nerve MD has produced great results for me. After the initial consultation I was scheduled to come once per week to receive transfusions. Most people bring a book to read or a show to watch on...
Very friendly receptionist, doctor exceptionally knowledgeable excellent exam honest I definitely recommend this place
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


